BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
Hadassah Medical Center
Jerusalén, IsraelPublicaciones en colaboración con investigadores/as de Hadassah Medical Center (4)
2023
2016
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477
-
International Myeloma Working Group recommendations for global myeloma care
Leukemia, Vol. 28, Núm. 5, pp. 981-992